Company / Income Tax
Ultragenyx Pharmaceutical Inc. Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$4.0M
FY2025
5-year range
-$2.0M / $5.7M
FY2021-FY2025
Trend
+100.0%
vs FY2024
Sector context
#52 of 204
Health Care
What the data says
Ultragenyx Pharmaceutical Inc.'s income tax of $4M is higher than 75% of companies in the Health Care sector (FY2025). Income Tax has fluctuated over the past 10 years, ranging from -$16M in FY2019 to $6M in FY2022.
Based on SEC 10-K filings.
$4M in FY2025 with a 5-year CAGR of +50.7%.
Increased from -$2M to $4M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -11.1%
- 5-Year CAGR
- +50.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 204This company $4.0M Sector average $118.7M
▼
-96.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +50.7%, indicating consistent growth.
- In FY2025, income tax increased 100.0% year-over-year.
- Ranks #52 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -2.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.0M | +100.0% |
| FY2024 | $2.0M | +200.0% |
| FY2023 | -$2.0M | -135.1% |
| FY2022 | $5.7M | +73.5% |
| FY2021 | $3.3M | +538.7% |
| FY2020 | $514.0K | +103.2% |
| FY2019 | -$16.2M | -3251.6% |
| FY2018 | $514.0K | +1368.6% |
| FY2017 | $35.0K | +0.0% |
| FY2016 | $35.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026